George Fennell - Jan 1, 2024 Form 3 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ George Fennell
Stock symbol
IDXX
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
3
Date filed
1/5/2024, 05:01 PM
Next filing
Feb 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IDXX Common Stock 5.1K Jan 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IDXX Restricted Stock Unit Jan 1, 2024 Common Stock 108 Direct F1
holding IDXX Restricted Stock Unit Jan 1, 2024 Common Stock 97 Direct F2
holding IDXX Restricted Stock Unit Jan 1, 2024 Common Stock 103 Direct F3
holding IDXX Restricted Stock Unit Jan 1, 2024 Common Stock 167 Direct F4
holding IDXX Restricted Stock Unit Jan 1, 2024 Common Stock 225 Direct F5
holding IDXX Restricted Stock Unit Jan 1, 2024 Common Stock 639 Direct F6
holding IDXX Incentive Stock Option (right-to-buy) Jan 1, 2024 Common Stock 1.61K $62.00 Direct F7
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 8.2K $62.00 Direct F8
holding IDXX Incentive Stock Option (right-to-buy) Jan 1, 2024 Common Stock 1.26K $79.54 Direct F9
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 9.99K $79.54 Direct F10
holding IDXX Incentive Stock Option (right-to-buy) Jan 1, 2024 Common Stock 1.48K $67.85 Direct F11
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 11.3K $67.85 Direct F12
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 5.3K $141.60 Direct F13
holding IDXX Incentive Stock Option (right-to-buy) Jan 1, 2024 Common Stock 706 $141.60 Direct F14
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 4.44K $178.26 Direct F15
holding IDXX Incentive Stock Option (right-to-buy) Jan 1, 2024 Common Stock 560 $178.26 Direct F16
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 4.83K $206.94 Direct F17
holding IDXX Incentive Stock Option (right-to-buy) Jan 1, 2024 Common Stock 483 $206.94 Direct F18
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 4.01K $299.78 Direct F19
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 1.81K $544.08 Direct F20
holding IDXX Incentive Stock Option (right-to-buy) Jan 1, 2024 Common Stock 183 $544.08 Direct F21
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 1.77K $505.53 Direct F22
holding IDXX Incentive Stock Option (right-to-buy) Jan 1, 2024 Common Stock 197 $505.53 Direct F23
holding IDXX Non-Qualified Stock Option (right-to-buy) Jan 1, 2024 Common Stock 1.45K $497.43 Direct F24
holding IDXX Incentive Stock Option (right-to-buy) Jan 1, 2024 Common Stock 201 $497.43 Direct F25
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of 544 restricted stock units ('RSU'). Each RSU represents a contingent right to receive one share of Issuer common stock and vest in five equal annual installments beginning on February 14, 2020.
F2 Grant of 390 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2021.
F3 Grant of 207 RSUs. Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four equal annual installments beginning on February 14, 2022.
F4 Grant of 223 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning ion February 14, 2023.
F5 Grant of 226 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2024.
F6 Grant of 639 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in one installment on June 1, 2026.
F7 Grant of option to buy 806 shares of Issuer common stock that vested in one installment on February 14, 2019, without giving effect to a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the Stock Split). The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect the Stock Split.
F8 Grant of option to buy 8,198 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2015, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect the Stock Split.
F9 Grant of option to buy 628 shares of Issuer common stock that vested in one installment on February 14, 2020, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect the Stock Split.
F10 Grant of option to buy 9,986 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2016, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect the Stock Split.
F11 Grant of option to buy 1,476 shares of Issuer common stock that vested on February 14, 2021.
F12 Grant of option to buy 11,345 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2017.
F13 Grant of option to buy 5,302 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2018.
F14 Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022.
F15 Grant of option to buy 4,437 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2019.
F16 Grant of option to buy 560 shares of Issuer common stock that vested in one installment on February 14, 2023.
F17 Grant of option to buy 4,826 shares of Issuer common stock that vests in five annual installments beginning on February 14, 2020.
F18 Grant of option to buy 483 shares of Issuer common stock that vests in one installment on February 14, 2024.
F19 Grant of option to buy 4,008 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2021.
F20 Grant of option to buy 1,805 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2022.
F21 Grant of option to buy 183 shares of Issuer common stock that vests in one installment on February 14, 2025.
F22 Grant of option to buy 1,768 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2023.
F23 Grant of option to buy 197 shares of Issuer common stock that vests in one installment on February 14, 2026.
F24 Grant of option to buy 1,454 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2024.
F25 Grant of option to buy 201 shares of Issuer common stock that vests in one installment on February 14, 2027.